Loading clinical trials...
Loading clinical trials...
Clostridium Botulinum Type A Neurotoxin Complex for Adjuvant Treatment of Depressive Disorders - a Randomized Controlled Pilot Study
Conditions
Interventions
clostridium botulinum toxin type A neurotoxin complex
0.9% NaCl solution
Locations
2
Germany
Medical School Hannover, Psychiatry, Social Psychiatry and Psychotherapy
Hanover, Germany
Psychiatry Hospital of the University of Basel, Basel, Switzerland
Basel, Basel Town, Switzerland
Start Date
August 1, 2009
Primary Completion Date
October 1, 2010
Completion Date
October 1, 2010
Last Updated
August 14, 2013
NCT07360600
NCT06793397
NCT07478393
NCT04123314
NCT06906939
NCT05851898
Lead Sponsor
University Hospital, Basel, Switzerland
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions